Pterin-6-aldehyde, a Cancer Cell Catabolite: Identification and Application in Diagnosis and Treatment of Human Cancer
Overview
Authors
Affiliations
Active folic acid degradation with the formation pterin-6-aldehyde is a previously undescribed characteristic of cancer cells in tissue culture. Neither normal adult epithelial and fibroblastic cells nor human amniotic cells nor mouse embryonic fibroblasts degrade folic acid to a measurable degree. Twenty-nine patients whose diagnoses were not revealed until after the test of their first morning urine for pterin-6-aldehyde was completed were studied for the presence or absence of pterin-6-aldehyde by thin-layer chromatography. Pterin-6-aldehyde was found in the urine at about 300 nmol/ml or greater only in those 13 patients with a tissue diagnosis of cancer. When the cancer was totally resected, the pterin-6-aldehyde was no longer found in the urine postoperatively. Pterin-6-aldehyde is not found in the urine of healthy patients at this level of detection unless their diets are supplemented with folic acid.
Establishing pteridine metabolism in a progressive isogenic breast cancer cell model.
Rasmussen L, Foulks Z, Burton C, Shi H Metabolomics. 2021; 18(1):2.
PMID: 34919200 PMC: 10067363. DOI: 10.1007/s11306-021-01861-9.
Wan Y, Tang L, Tan T J Fluoresc. 2010; 20(6):1191-8.
PMID: 20419340 DOI: 10.1007/s10895-010-0667-4.
Mechanism of Substrate and Inhibitor Binding of Rhodobacter capsulatus Xanthine Dehydrogenase.
Dietzel U, Kuper J, Doebbler J, Schulte A, Truglio J, Leimkuhler S J Biol Chem. 2008; 284(13):8768-76.
PMID: 19109249 PMC: 2659235. DOI: 10.1074/jbc.M808114200.
Ziegler I, Kolb H, Bodenberger U, Wilmanns W Blut. 1982; 44(5):261-70.
PMID: 7042006 DOI: 10.1007/BF00320700.
Urinary unconjugated pteridines: general considerations.
Stea B, Smith R Surv Immunol Res. 1982; 1(4):357-64.
PMID: 6764849 DOI: 10.1007/BF02918548.